TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

EuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

AIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.

Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

BIOTECHNOLOGY AND BIOENGINEERING, published by Wiley, is a leading journal in the domains of applied microbiology, biotechnology, and bioengineering. With an ISSN of 0006-3592 and E-ISSN of 1097-0290, this journal has established itself as an essential resource for researchers, professionals, and students aiming to advance their knowledge and stay updated on cutting-edge innovations and methodologies in biotechnology. The journal has a commendable impact factor, and it is ranked in the second quartile (Q2) across multiple categories for 2023. This positions it favorably among its peers, underscoring its significance in the scientific community; for example, it ranks 23rd out of 127 in the field of Applied Microbiology and Biotechnology. As a hub of critical research findings and technological advancements, BIOTECHNOLOGY AND BIOENGINEERING invites contributions that push the boundaries of biotechnological applications, fostering a deeper understanding and development of sustainable solutions to current global challenges.